NanoViricides Shares Are Trading Higher After the Company Announced That It Ultra-broad-spectrum Antiviral NV-387 Was Found to Be Effective in Protecting Lungs From Damage in a Lethally Infected Influenza A H3N2 Mouse Model.
NanoViricides Shares Are Trading Higher After the Company Announced That It Ultra-broad-spectrum Antiviral NV-387 Was Found to Be Effective in Protecting Lungs From Damage in a Lethally Infected Influenza A H3N2 Mouse Model.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.